V. Ascalone

460 total citations
30 papers, 397 citations indexed

About

V. Ascalone is a scholar working on Analytical Chemistry, Pharmacology and Spectroscopy. According to data from OpenAlex, V. Ascalone has authored 30 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Analytical Chemistry, 15 papers in Pharmacology and 12 papers in Spectroscopy. Recurrent topics in V. Ascalone's work include Analytical Methods in Pharmaceuticals (17 papers), Antibiotics Pharmacokinetics and Efficacy (13 papers) and Analytical Chemistry and Chromatography (12 papers). V. Ascalone is often cited by papers focused on Analytical Methods in Pharmaceuticals (17 papers), Antibiotics Pharmacokinetics and Efficacy (13 papers) and Analytical Chemistry and Chromatography (12 papers). V. Ascalone collaborates with scholars based in Italy, Czechia and Switzerland. V. Ascalone's co-authors include Marilena Ripamonti, M. Locatelli, Bo Li, P.L. Morselli, J. P. Thenot, P. L. Morselli, M. Cisternino, B. Ludwig, G. Bianchetti and Mario Regazzi and has published in prestigious journals such as Journal of Chromatography A, Acta Psychiatrica Scandinavica and British Journal of Clinical Pharmacology.

In The Last Decade

V. Ascalone

30 papers receiving 356 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V. Ascalone Italy 14 182 151 116 51 43 30 397
P. Haefelfinger Switzerland 10 135 0.7× 114 0.8× 120 1.0× 37 0.7× 30 0.7× 28 375
S. K. Wahba Khalil United States 14 134 0.7× 150 1.0× 126 1.1× 47 0.9× 20 0.5× 32 425
R.R. Brodie United States 15 84 0.5× 135 0.9× 110 0.9× 76 1.5× 46 1.1× 42 570
J.P. Dubois Switzerland 12 88 0.5× 100 0.7× 113 1.0× 56 1.1× 21 0.5× 24 383
Robert Dugal Canada 12 208 1.1× 109 0.7× 188 1.6× 86 1.7× 98 2.3× 31 712
M. Josefsson Sweden 9 73 0.4× 96 0.6× 120 1.0× 79 1.5× 29 0.7× 13 366
J. Brès France 13 157 0.9× 111 0.7× 48 0.4× 50 1.0× 18 0.4× 23 455
Clark March United States 9 78 0.4× 96 0.6× 82 0.7× 28 0.5× 47 1.1× 18 364
J. Klı́ma Czechia 14 178 1.0× 301 2.0× 162 1.4× 29 0.6× 71 1.7× 16 489
Martin R. Hackman United States 12 186 1.0× 119 0.8× 132 1.1× 24 0.5× 12 0.3× 16 518

Countries citing papers authored by V. Ascalone

Since Specialization
Citations

This map shows the geographic impact of V. Ascalone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Ascalone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Ascalone more than expected).

Fields of papers citing papers by V. Ascalone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Ascalone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Ascalone. The network helps show where V. Ascalone may publish in the future.

Co-authorship network of co-authors of V. Ascalone

This figure shows the co-authorship network connecting the top 25 collaborators of V. Ascalone. A scholar is included among the top collaborators of V. Ascalone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Ascalone. V. Ascalone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Ascalone, V., et al.. (1996). Suitability of automated capillary and micro liquid chromatography for routine determination of drugs in human plasma samples from clinical pharmacokinetic investigations. Journal of High Resolution Chromatography. 19(9). 503–510. 11 indexed citations
5.
6.
7.
8.
Ripamonti, Marilena, et al.. (1993). Determination of a new calcium antagonist in human plasma by liquid extraction enrichment and HPLC with UV detection. Chromatographia. 36(1). 343–346. 1 indexed citations
9.
Rosenzweig, P., Steve Warrington, Alain Patat, et al.. (1993). Alpidem: Lack of sedative effect on psychomotor performance in therapeutic doses. Human Psychopharmacology Clinical and Experimental. 8(6). 409–415. 2 indexed citations
10.
Ascalone, V., et al.. (1992). Determination of zolpidem, a new sleep-inducing agent, and its metabolites in biological fluids: pharmacokinetics, drug metabolism and overdosing investigations in humans. Journal of Chromatography B Biomedical Sciences and Applications. 581(2). 237–250. 43 indexed citations
11.
Bianchetti, G., Mario Regazzi, R Rondanelli, V. Ascalone, & P. L. Morselli. (1991). Bioavailability of diltiazem as a function of the administered dose. Biopharmaceutics & Drug Disposition. 12(5). 391–401. 20 indexed citations
12.
Nielsen, Niels Peter, et al.. (1990). Therapeutic effects of fengabine, a new GABAergic agent, in depressed outpatients: a double‐blind study versus clomipramine. Acta Psychiatrica Scandinavica. 82(5). 366–371. 19 indexed citations
13.
Ascalone, V., et al.. (1989). Determination of the gabaergic antidepressant drug fengabine and some of its metabolites in plasma by capillary gas chromatography with electron-capture detection. Journal of Chromatography B Biomedical Sciences and Applications. 490(1). 81–90. 1 indexed citations
14.
Ascalone, V., et al.. (1989). Automated high-performance liquid chromatography with column switching for on-line clean-up and analysis of diltiazem and metabolites in human plasma. Journal of Chromatography B Biomedical Sciences and Applications. 495. 358–360. 13 indexed citations
15.
Ascalone, V. & Bo Li. (1987). Automated high-performance liquid chromatographic and column-switching technique for on-line clean-up and analysis of diltiazem in human plasma. Journal of Chromatography B Biomedical Sciences and Applications. 423. 239–249. 21 indexed citations
16.
Ascalone, V., et al.. (1987). Determination of alpidem and its metabolites in human plasma by high-performance liquid chromatography and fluorimetric detection. Journal of Chromatography B Biomedical Sciences and Applications. 414(1). 101–108. 7 indexed citations
17.
Ascalone, V., et al.. (1985). A pharmacokinetic study on midazolam in compensated liver cirrhosis.. PubMed. 5(6). 405–11. 16 indexed citations
18.
Ascalone, V.. (1981). Assay of trimethoprim, sulfadiazine and its N4-acetyl metabolite in biological fluids by normal-phase high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 224(1). 59–66. 29 indexed citations
19.
Ascalone, V.. (1980). Determination of chlordiazepoxide and its metabolites in human plasma by reversed-phase high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 181(1). 141–146. 8 indexed citations
20.
Ascalone, V.. (1978). [Specific gas chromatographic determination of trimethoprim, sulfamethoxazole and their N4-acetylated metabolites in human biological fluids, at therapeutic and lower concentrations, using a new nitrogen detector].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 117(3). 176–86. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P. Haefelfinger Breakdown of academic impact, for papers by S. K. Wahba Khalil Breakdown of academic impact, for papers by R.R. Brodie Breakdown of academic impact, for papers by J.P. Dubois Breakdown of academic impact, for papers by Robert Dugal Breakdown of academic impact, for papers by M. Josefsson Breakdown of academic impact, for papers by J. Brès Breakdown of academic impact, for papers by Clark March Breakdown of academic impact, for papers by J. Klı́ma Breakdown of academic impact, for papers by Martin R. Hackman
Rankless by CCL
2026